Ursula Paulus

Standard and Increased-Dose BEACOPP Chemotherapy Compared with COPP-ABVD for Advanced Hodgkin's Disease

Volker Diehl, Jeremy Franklin, Michael Pfreundschuh et al. · New England Journal of Medicine · 2003 · 833 citations · Full text

Medicine, Oncology, Pharmacology +11

Two Cycles of Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine Plus Extended-Field Radiotherapy Is Superior to Radiotherapy Alone in Early Favorable Hodgkin's Lymphoma: Final Results of the GHSG HD7 Trial

Andreas Engert, Jeremy Franklin, Hans Theodor Eich et al. · Journal of Clinical Oncology · 2007 · 261 citations · Full text

Medicine, Oncology, Radiation Oncology +16

Eight Cycles of Escalated-Dose BEACOPP Compared With Four Cycles of Escalated-Dose BEACOPP Followed by Four Cycles of Baseline-Dose BEACOPP With or Without Radiotherapy in Patients With Advanced-Stage Hodgkin's Lymphoma: Final Analysis of the HD12 Trial of the German Hodgkin Study Group

Peter Borchmann, Heinz Haverkamp, Volker Diehl et al. · Journal of Clinical Oncology · 2011 · 190 citations

Medicine, Oncology, Radiation Oncology +11

Low-Dose Radiation Is Sufficient for the Noninvolved Extended-Field Treatment in Favorable Early-Stage Hodgkin’s Disease: Long-Term Results of a Randomized Trial of Radiotherapy Alone

E. Dühmke, Jeremy Franklin, Michael Pfreundschuh et al. · Journal of Clinical Oncology · 2001 · 113 citations

Medicine, Oncology, Radiation Oncology +15

Risk analysis and risk adapted on-site monitoring in noncommercial clinical trials

Oana Brosteanu, Peggy Houben, Kristina Ihrig et al. · Clinical Trials · 2009 · 95 citations

Pharmacy, Risk Management, Patient Safety +12